STA Liatest D Dimer and Health Technology Assessment- An Economic Report
An Economic Evaluation of STA-Liatest D-Di for Exclusion of Venous thromboembolism (VTE) was undertaken by an international advisory company.
The Value Proposition for both patient and healthcare systems demonstrates improved patient outcomes, shorter length of stay and reduced associated costs.
Click
here to read more
